Citigroup Inc Harpoon Therapeutics, Inc. Transaction History

Citigroup Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	SELL	$0.6 - $1.41 $237 - $558	-396 Reduced 91.24%	38 $0
Q3 2022 Nov 10, 2022	SELL	$0.94 - $2.56 $264 - $719	-281 Reduced 39.3%	434 $0
Q2 2022 Aug 10, 2022	SELL	$1.78 - $5.02 $1,174 - $3,313	-660 Reduced 48.0%	715 $1,000
Q1 2022 May 12, 2022	SELL	$3.54 - $8.08 $15,473 - $35,317	-4,371 Reduced 76.07%	1,375 $7,000
Q4 2021 Feb 10, 2022	BUY	$5.69 - $7.83 $10,976 - $15,104	1,929 Added 50.54%	5,746 $43,000
Q3 2021 Nov 10, 2021	BUY	$7.88 - $14.0 $30,077 - $53,438	3,817 New	3,817 $30,000

353K

Ticker HARP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,106,800
Description
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.